In this study, the effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2A receptor antagonist, on platelet aggregation at the site of injured carotid artery endothelium was examined. The rat common carotid artery was clamped for 30 min to induce endothelial injury. Sarpogrelate hydrochloride was administered before and after the injury, and the effects were compared with those in rats receiving sham operation only and those receiving clipping injury but no sarpogrelate hydrochloride. The animals were killed 24 h after the procedure. The common carotid artery was examined by scanning electron microscopy and stained immunochemically for factor VIII. Sarpogrelate hydrochloride treatment was associated with reduced aggregation of platelets on electron microscopy and lower expression of factor VIII at the injured intima. Sarpogrelate hydrochloride has an inhibitory effect on platelet aggregation at the intima in the acute stage after injury, suggesting that this drug may be used to prevent early ischaemic complications after surgical or endovascular arterial intervention.
AshfordTPFreimanDG: Platelet aggregation at sites of minimal endothelial injury. An electron microscopic study. Am J Pathol1968; 53: 599–607.
2.
BarradasMAGillDSFonsecaVAMikhailidisDPDandonaP: Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest1988; 18: 399–404.
3.
MurakamiYIshinagaYSanoKMurakamiRKinoshitaYKitamuraJ: Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina. Clin Cardiol1996; 19: 473–476.
4.
LeoscoDFineschiMPierliCFiaschiAFerraraNBiancoS: Intracoronary serotonin release after high-pressure coronary stenting. Am J Cardiol1999; 84: 1317–1322.
5.
de ClerckFFJanssenPA: Amplification mechanisms in platelet activation and arterial thrombosis. J Hypertens Suppl1990; 8: S87–S93.
6.
de ClerckFDavidJLJanssenPA: Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist. Agents Actions1982; 12: 388–397.
HaraHOsakabeMKitajimaATamaoYKikumotoR: MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb Haemost1991; 65: 415–420.
9.
QiROzakiYSatohKKurotaKAsazumaNYatomiY: Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin. Thromb Res1996; 81: 43–54.
10.
MalyszkoJPawlakKMalyszkoSMysliwiecMTakadaYTakadaA: MCI-9042 and aggregation of uremic and normal platelets. J Serotonin Res1996; 4: 251–258.
11.
NakamuraKKariyazonoHMoriyamaYToyohiraHKuboHYotsumotoG: Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin. Blood Coagul Fibrinolysis1999; 10: 513–519.
12.
NakamuraKKariyazonoHMasudaHSakataRYamadaK: Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans. Blood Coagul Fibrinolysis2001; 12: 391–397.
13.
KurodaSKamiyamaHAbeHHoukinKIsobeMMitsumoriK: Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion. Neurosurgery1993; 32: 912–918; discussion 918–919.
14.
DujovnyMOsgoodCPBarrionuevoPJPerlinAKossovskyN: SEM evaluation of endothelial damage following temporary middle cerebral artery occlusion in dogs. J Neurosurg1978; 48: 42–48.
15.
TsukaharaTYonekawaYYamamotoMKakuYOgataNTaniguchiT: Regeneration of the rat carotid artery after clipping injury. Part I. A morphological study. Neurosurgery1993; 32: 66–71; discussion 71–72.
ThurstonJBBunckeHJChaterNLWeinsteinPR: A scanning electron microscopy study of micro-arterial damage and repair. Plast Reconstr Surg1976; 57: 197–203.
18.
TaniKKubotaTYamashimaTItoHYamamotoS: Ultrastructural study of arterial endothelial cells after temporary clipping (in Japanese). Neurol Med Chir (Tokyo)1988; 28: 109–116.
19.
SchrorK: Antiplatelet drugs. A comparative review. Drugs1995; 50: 7–28.
20.
HoyerDClarkeDEFozardJRHartigPRMartinGRMylecharaneEJ: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev1994; 46: 157–203.
21.
TakadaYTakadaAUranoT: MCI-9042, the new selective antagonist of serotonergic (5-HT2A) receptors. Cardiovasc Drug Rev1997; 15: 101–121.
22.
ShimizuTYamadaYTashitaAYamamotoKKotakiHSawadaY: Pharmacokinetic analysis of antiplatelet effect of sarpogrelate hydrochloride and its application to drug dosage regimen - modeling based on reversible inhibition of 5-HT2 serotonergic receptor in the platelet membrane by sarpogrelate hydrochloride and its metabolite (in Japanese, English abstract). Yakugaku Zasshi1999; 119: 850–860.
23.
HaraHShimadaHKitajimaATamaoY: Effect of (+/−)-2-(dimethylamino)-1-[[o-(m-methoxyphenyl)phenoxy]methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. Arzneimittelforschung1991; 41: 616–620.
